ArticleJournal of lipid research2026
USP25 deficiency suppresses diet-induced obesity via ubiquitination and degradation of PARP1 and Elovl3 downregulation.
Article in Journal of lipid research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ubiquitin-specific protease 25 (USP25) is a key regulator of lipid metabolism and insulin-stimulated glucose transport. Nonetheless, its involvement in adipocyte maturation remains uncertain. In this study, we aimed to explore how the expression of USP25 contributes to obesity induced by a high-fat diet (HFD). Usp25-KO and WT mice, maintained on either a normal diet or an HFD, were evaluated for weight gain, insulin resistance status, adipose tissue development, energy metabolism, and systemic inflammation status. In vitro, 3T3-L1 cells were induced to mature adipocytes in a specific culture medium. We found that USP25 expression decreased in obese mice subjected to long-term HFD feeding and in mature adipocytes. Usp25-KO mice showed restrained adipose tissue development and improved insulin resistance, whereas USP25-deficient preadipocytes failed to differentiate. RNA sequencing analysis showed the downregulation of lipid synthesis-related pathways in Usp25-KO mice. Mechanistically, USP25 binds to and stabilizes poly (ADP-ribose) polymerase 1 through deubiquitination, whereas poly (ADP-ribose) polymerase 1 facilitates preadipocyte differentiation and maturation by regulating the elongation of very long-chain fatty acid protein 3. These findings show the essential role of USP25 in adipocyte differentiation and lipid metabolism, suggesting that targeting USP25 ablation in adipocytes could be a promising therapeutic strategy for obesity treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.